YOLFTbeta
05

BINEX Co. Ltd

053030 · KQ · Healthcare / Pharmaceuticals

6,390.00KRW+30.00 (+0.47%)

Price History

Full chart

Market Stats

Previous Close6,360.00
Open6,310.00
Day Range6,310.00 – 6,780.00
52-Week Range5,500.00 – 16,800.00
Volume146.31K
Market Cap207.01B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.69
50-Day Avg6,665.40
200-Day Avg10,459.70

About

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOWon-Seok Kim
  • Employees553
  • Headquarters7-48 SongDo-Dong, Incheon, South Korea, 406-840, Korea
  • Websitehttps://www.bi-nex.co.kr

Leadership

  • Won-Seok KimHead of Production Division and Director · b. 1963
  • Young-Cheol SonHead of Management Support Division and Director · b. 1964
  • Jung-Jin LeeHead of Bio-Tech Research Center and Director · b. 1964
  • Byung-In LeeHead of Bus. Operation Division and Director · b. 1965
  • Jung-Won SeoHead of Bio Processing Division and Director · b. 1962
  • Myung-Cheol LeeManaging Director · b. 1958
  • Soo-Yong JinManaging Director · b. 1968
  • Mr. Hyuk-Jong LeeManaging Director · b. 1969
  • Doo-Hyun KimVP · b. 1952
  • Jung-Tak MoonChief Exec. Officer · b. 1966

Financials

Income Statement

Currency: KRW2004-12-312005-12-312006-12-312007-12-312011-12-312012-12-312013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue15.80B30.01B34.66B36.06B53.46B55.13B57.30B66.54B80.92B78.03B104.04B125.26B132.98B134.40B156.68B154.82B130.05B168.47B
Growth (%)-+89.92%+15.52%+4.02%+48.27%+3.13%+3.93%+16.13%+21.62%-3.58%+33.34%+20.39%+6.16%+1.07%+16.58%-1.18%-16.00%+29.55%
Cost of Revenue7.03B14.29B15.61B16.16B23.00B26.57B33.82B36.39B51.83B49.63B55.79B68.49B69.95B74.41B86.17B97.88B108.76B123.40B
Gross Profit------18.25B30.15B29.10B28.40B48.25B56.77B63.03B59.99B70.50B56.95B21.29B45.07B
Gross Margin------31.85%45.32%35.95%36.40%46.37%45.32%47.40%44.63%45.00%36.78%16.37%26.75%
Operating Expense------24.49B31.49B31.86B37.10B41.37B45.49B46.89B46.76B53.32B53.58B52.04B49.61B
Operating Income1.62B3.47B4.11B3.58B3.61B196.24M-6.25B-1.34B-2.77B-8.70B6.88B11.28B16.14B13.22B17.18B3.37B-30.75B-4.53B
Operating Margin10.25%11.55%11.86%9.94%6.76%0.36%-10.90%-2.01%-3.42%-11.15%6.61%9.00%12.14%9.84%10.96%2.17%-23.65%-2.69%
EBITDA--------------25.60B16.76B-24.20B12.65B
EBITDA Margin--------------16.34%10.82%-18.61%7.51%
Net Income1.23B2.45B2.99B2.99B3.39B--4.07B-9.29B-3.00B-11.29B6.34B8.50B6.41B19.09B12.44B4.67B-35.07B-3.23B
Net Income Margin7.76%8.16%8.62%8.28%6.33%--7.10%-13.96%-3.71%-14.48%6.09%6.79%4.82%14.21%7.94%3.02%-26.97%-1.91%
R&D----1.89B1.64B2.27B1.17B817.80M622.05M894.57M1.04B1.10B384.00M1.62B1.31B1.20B1.16B
R&D as % of Total Revenue----3.53%2.97%3.96%1.76%1.01%0.80%0.86%0.83%0.82%0.29%1.03%0.85%0.92%0.69%
Interest Expense000000000002.12B1.44B1.69B2.06B1.97B2.30B4.45B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.70%1.08%1.26%1.32%1.27%1.77%2.64%

Balance Sheet

Currency: KRW2004-12-312005-12-312006-12-312007-12-312011-12-312012-12-312013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets31.76B42.55B46.30B49.13B100.68B143.80B122.27B176.11B177.10B167.77B190.42B202.78B270.09B272.49B298.41B257.01B279.39B311.42B
Total Liabilities18.44B13.56B14.40B14.63B30.10B51.90B24.82B31.97B36.55B39.02B40.99B42.29B96.88B92.07B106.80B75.69B97.78B123.97B
Total Equity11.32B26.65B29.04B31.43B68.63B89.96B96.77B144.14B140.55B128.75B149.43B160.50B173.22B180.42B191.61B181.31B181.36B187.30B
Cash2.37B6.79B5.05B3.70B11.16B18.82B11.41B11.79B6.16B11.29B13.11B18.49B50.58B2.14M3.34M8.16B25.74B18.36B
Total Debt-------22.95B35.00B3.00B-23.39B56.59B-----
Net Debt-----------4.67B5.93B-23.09B38.59B34.16B73.51B

Cash Flow

Currency: KRW2004-12-312005-12-312006-12-312007-12-312011-12-312012-12-312013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.48B2.52B3.12B1.26B--1.85B-4.50B3.80B8.14B13.56B10.78B19.92B28.07B17.06B3.78B-9.43B-23.27B
Investing Cash Flow------11.70B-61.97B-12.25B-4.34B-14.07B-2.42B-28.17B-13.80B-39.12B-14.18B-2.85B-
Financing Cash Flow-7.52B329.16M367.17M6.45B49.93B-17.56B54.71B2.77B1.07B2.32B-2.95B40.77B-14.81B3.22B-12.57B29.84B-
Capital Expenditure02.11B3.67B5.64B4.43B1.66B2.10B65.08B5.34B2.27B2.55B8.79B7.70B11.85B36.45B16.15B11.35B23.26B
Free Cash Flow------------10.37B8.28B-19.39B-12.38B-20.78B-46.53B
Dividends Paid--600.00M600.00M--------------
FCF to OCF------------52.07%29.49%-113.65%-327.61%220.45%199.99%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 29, 2014Nov 28, 2014May 16, 2015Aug 18, 2015Nov 4, 2015Feb 12, 2016May 16, 2016Aug 12, 2016Nov 11, 2016Feb 9, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Mar 7, 2018May 15, 2018Aug 14, 2018Nov 13, 2018Mar 6, 2019Mar 31, 2019Jun 30, 2019Nov 10, 2019Feb 6, 2020Mar 31, 2020Aug 11, 2020Nov 11, 2020Mar 2, 2021May 16, 2021Aug 13, 2021Nov 12, 2021Mar 2, 2022May 13, 2022Aug 15, 2022Nov 13, 2022Mar 2, 2023May 9, 2023Aug 11, 2023Nov 14, 2023Mar 15, 2024May 14, 2024Aug 14, 2024Nov 14, 2024Mar 14, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Mar 13, 2026May 15, 2026Aug 14, 2026
EPS Estimate----------------------------44.0052.00-------------------------------167.82-148.29183.19-9.7641.2086.7620.12-105.197.93
EPS Actual1.671.7946.46-164.00-82.67-11.4445.00-164.0029.4131.0050.1758.5821.96-6.00-60.68-335.19-35.0143.20-3.66-106.715.8437.8028.2521.207.9445.16-293.4810.36-92.00-19.00-54.80-7.10-174.67-95.28-110.19-39.75-57.0069.00230.0042.2293.1854.1883.1149.61181.00135.00-159.18270.0056.00159.00128.8560.92178.97157.79-2.65228.4341.78-177.7856.40-315.98-172.00-382.00-256.000.3944.00-30.00-115.00-297.00-471.00
Surprise-----------------------------309.09%-136.54%-------------------------------2.49%-157.60%-239.75%103.98%6.80%-134.58%-671.57%-182.35%-6039.47%
Timing---------------------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market--After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap207.01B
Enterprise Value279.30B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.22
Price / Book1.20
Revenue (TTM)154.97B
Gross Profit (TTM)59.92B
EBITDA29.40B
Profit Margin10.65%
Operating Margin14.65%
Return on Equity-1422.82%
Return on Assets5.22%
Shares Outstanding31.19M
Shares Float30.41M
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20081×
45.24Dec 29, 2008
20071×
45.24Dec 27, 2007
20061×
45.24Dec 27, 2006
20051×
45.24Dec 28, 2005

Stock Splits

  • May 2, 20112:1
  • Aug 7, 20091250:1131
  • Sep 20, 2005299:279